{"id":36518,"date":"2025-01-10T16:35:34","date_gmt":"2025-01-10T16:35:34","guid":{"rendered":"https:\/\/new.igihe.com\/french\/Le-Rwanda-s-engage-a-la-production-locale-de-medicaments-en-Afrique-36518\/"},"modified":"2025-01-10T16:35:21","modified_gmt":"2025-01-10T16:35:21","slug":"Le-Rwanda-s-engage-a-la-production-locale-de-medicaments-en-Afrique","status":"publish","type":"post","link":"https:\/\/new.igihe.com\/french\/Le-Rwanda-s-engage-a-la-production-locale-de-medicaments-en-Afrique\/","title":{"rendered":"Le Rwanda s&#8217;engage \u00e0 la production locale de m\u00e9dicaments en Afrique"},"content":{"rendered":"<p>Dans un communiqu\u00e9 publi\u00e9 le 10 janvier 2025, les bureaux de la pr\u00e9sidence ont indiqu\u00e9 que l\u2019objectif principal de cette rencontre \u00e9tait de discuter sur un renforcement d&#8217;investissements dans la production de m\u00e9dicaments, afin d\u2019am\u00e9liorer leur accessibilit\u00e9 et leur qualit\u00e9 \u00e0 travers le continent africain.<\/p>\n<p>Le gouvernement s&#8217;engage \u00e0 trouver des solutions durables pour am\u00e9liorer la sant\u00e9 en Afrique, en visant principalement \u00e0 combler le d\u00e9ficit en m\u00e9dicaments et en vaccins pour lutter efficacement contre diverses maladies.<\/p>\n<p>Cette initiative a \u00e9merg\u00e9, suite \u00e0 la p\u00e9nurie de vaccins contre la COVID-19, qui a particuli\u00e8rement affect\u00e9 les pays \u00e0 faibles revenus, notamment en Afrique. Pour y rem\u00e9dier, le gouvernement avait engag\u00e9 des discussions avec des partenaires du secteur pharmaceutique, qui a conduit \u00e0 l\u2019ouverture, en d\u00e9cembre 2023, d\u2019une usine BioNTech de production de m\u00e9dicaments et de vaccins \u00e0 Kigali.<\/p>\n<p>\u00ab Nous sommes pr\u00eats \u00e0 lancer la production de vaccins en Afrique. BioNTech s&#8217;engage \u00e0 assurer un acc\u00e8s \u00e9quitable aux vaccins sur l&#8217;ensemble du continent. C&#8217;est cette mission qui nous a pouss\u00e9s \u00e0 \u00e9tablir notre pr\u00e9sence ici \u00bb, a d\u00e9clar\u00e9 Aneto Okeke, responsable de l&#8217;usine BioNTech au Rwanda.<\/p>\n<p>Le Rwanda collabore \u00e9galement avec Bayer, groupe pharmaceutique allemand, et Minapharm, une entreprise \u00e9gyptienne, dans le but de renforcer la production locale de m\u00e9dicaments. L&#8217;objectif est de diminuer la d\u00e9pendance aux importations en fabriquant ces produits directement en Afrique, afin de mieux satisfaire les besoins sanitaires de la population.<\/p>\n<figure class=\"spip-document spip-document-56849 aligncenter\"><img decoding=\"async\" src=\"https:\/\/fr.igihe.com\/IMG\/jpg\/apkpharma_1.jpg\" alt=\"Le Pr\u00e9sident Paul Kagame a rencontr\u00e9 Stefan Oelrich, directeur g\u00e9n\u00e9ral de Bayer Pharmaceuticals, et le Dr Shaheer Bardissi, directeur g\u00e9n\u00e9ral de Minapharm Pharmaceuticals.\" \/><\/figure>\n<figure class=\"spip-document spip-document-56850 aligncenter\"><img decoding=\"async\" src=\"https:\/\/fr.igihe.com\/IMG\/jpg\/apkpharma_2.jpg\" alt=\"Les discussions portaient sur de potentiels investissements concernant la production locale de m\u00e9dicaments en Afrique.\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Le Pr\u00e9sident Paul Kagame a rencontr\u00e9 Stefan Oelrich, directeur g\u00e9n\u00e9ral de Bayer Pharmaceuticals, et le Dr Shaheer Bardissi, directeur g\u00e9n\u00e9ral de Minapharm Pharmaceuticals, dans le but de discuter sur de potentiels investissements dans la production locale de m\u00e9dicaments en Afrique. Au cours de cette rencontre, le Pr\u00e9sident Kagame a soulign\u00e9 l&#8217;importance d&#8217;am\u00e9liorer l&#8217;acc\u00e8s aux m\u00e9dicaments pour un plus grand nombre de personnes \u00e0 travers le continent africain.<\/p>\n","protected":false},"author":488,"featured_media":4000056851,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7529],"tags":[7605],"byline":[9865],"hashtag":[],"class_list":["post-36518","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite-3","tag-homenews","byline-alain-bertrand-tunezerwe"],"bylines":[{"id":9865,"name":"Alain Bertrand Tunezerwe","slug":"alain-bertrand-tunezerwe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":452}],"contributors":[{"id":9865,"name":"Alain Bertrand Tunezerwe","slug":"alain-bertrand-tunezerwe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":452}],"featured_image":{"id":4000056851,"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/apkpharma_2.jpg","alt":"","caption":"","mime_type":"image\/jpeg","width":0,"height":0,"sizes":{"thumbnail":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/apkpharma_2.jpg","width":1,"height":1},"medium":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/apkpharma_2.jpg","width":1,"height":1},"medium_large":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/apkpharma_2.jpg","width":1,"height":1},"large":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/apkpharma_2.jpg","width":1,"height":1},"full":{"url":"https:\/\/fr-images.igihe.com\/IMG\/logo\/apkpharma_2.jpg","width":0,"height":0}}},"_links":{"self":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/36518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/users\/488"}],"replies":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/comments?post=36518"}],"version-history":[{"count":0,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/posts\/36518\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/media\/4000056851"}],"wp:attachment":[{"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/media?parent=36518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/categories?post=36518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/tags?post=36518"},{"taxonomy":"byline","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/byline?post=36518"},{"taxonomy":"hashtag","embeddable":true,"href":"https:\/\/new.igihe.com\/french\/wp-json\/wp\/v2\/hashtag?post=36518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}